Colossal Biosciences

Colossal Biosciences is a biotechnology startup founded in 2021 with the ambitious slogan "The de-extinction company." The company specializes in genetic engineering and bioscience, focusing on advancing the field of genomics through disruptive technologies. Their primary areas of focus include extinct species restoration, protection of critically endangered species, and the repopulation of essential ecosystems. Colossal distinguishes itself as the pioneer in applying CRISPR technology for species de-extinction, starting with the woolly mammoth.

With a strong emphasis on the pressing need to restore Earth's ecological balance, Colossal also aims to address future economic and biological challenges through state-of-the-art science and technological innovation. The company's overarching vision aligns with the imperative of restoring the planet to a healthier state while concurrently devising solutions for the evolving needs of humanity. Although specific details about their headquarters, last investments, and investors are not available at this time, the groundbreaking nature of Colossal Biosciences in the realm of genetic engineering and its potential impact on environmental conservation and the future of life on Earth make it a compelling prospect for investors and industry observers alike.